in Re SmithKline Beecham Corporation D/B/A Glaxo SmithKline

Court of Appeals of Texas

in Re SmithKline Beecham Corporation D/B/A Glaxo SmithKline

DecidedJanuary 23, 2009

Docket14-08-00540-CV

StatusPublished

This text of in Re SmithKline Beecham Corporation D/B/A Glaxo SmithKline (in Re SmithKline Beecham Corporation D/B/A Glaxo SmithKline) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

in Re SmithKline Beecham Corporation D/B/A Glaxo SmithKline, (Tex. Ct. App. 2009).

Pincite

Opinion

Dismissed and Memorandum Opinion filed January 23, 2009

Dismissed and Memorandum Opinion filed January 23, 2009.

In The

Fourteenth Court of Appeals

____________

NO. 14-08-00540-CV

IN RE SMITHKLINE BEECHAM CORPORATION D/B/A GLAXOSMITHKLINE, Relator

ORIGINAL PROCEEDING

WRIT OF MANDAMUS

M E M O R A N D U M O P I N I O N

On June 27, 2008, relator, SmithKline Beecham Corporation d/b/a GlaxoSmithKline, file a petition for writ of mandamus. See Tex. Gov=t Code Ann. ' 22.221 (Vernon 2004); see also Tex. R. App. P. 52. On January 15, 2009, relator filed a motion to dismiss this original proceeding because the underlying case has settled. See Tex. R. App. P. 42.1. The motion is granted.

Accordingly, relator=s petition for writ of mandamus is ordered dismissed.

PER CURIAM

Panel consists of Justices Yates, Anderson, and Brown.

Free access — add to your briefcase to read the full text and ask questions with AI